1 – 21 of 21
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”
(
- Contribution to journal › Article
- 2023
-
Mark
Implementation of precision medicine in healthcare—A European perspective
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Trailblazing precision medicine in Europe : A joint view by Genomic Medicine Sweden and the Centers for Personalized Medicine, ZPM, in Germany
(
- Contribution to journal › Article
-
Mark
Tackling Mantle Cell Lymphoma in Europe
(
- Contribution to journal › Article
-
Mark
Cardiovascular Simulation as a Decision Support Tool
2022) p.261-271(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2021
-
Mark
Perspectives on a Way Forward to Implementation of Precision Medicine in Patients With Diabetic Kidney Disease; Results of a Stakeholder Consensus-Building Meeting
(
- Contribution to journal › Article
-
Mark
Organoid technology for personalized pancreatic cancer therapy
(
- Contribution to journal › Scientific review
- 2020
-
Mark
Neuroimaging, genetic, clinical, and demographic predictors of treatment response in patients with social anxiety disorder
(
- Contribution to journal › Article
-
Mark
Association is not prediction : A landscape of confused reporting in diabetes – A systematic review
(
- Contribution to journal › Article
- 2019
-
Mark
Advancing research toward faster diagnosis, better treatment, and end of stigma in epilepsy
2019) In Epilepsia(
- Contribution to journal › Article
-
Mark
Two subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectives
(
- Contribution to journal › Scientific review
- 2018
-
Mark
From fixed activities to personalized treatments in radionuclide therapy : lost in translation?
(
- Contribution to journal › Article
-
Mark
Identification and use of personalized genomic markers for monitoring circulating tumor DNA
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2017
-
Mark
Patenting Human Genes in Europe: and how it compares to the US and Australia
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2015
-
Mark
Life after Myriad: the uncertain future of patenting biomedical innovation and personalised medicine in an international context
(
- Contribution to journal › Article
- 2014
-
Mark
The significance of lipid peroxidation in cardiovascular disease
(
- Contribution to journal › Article
-
Mark
A New Look at Drugs Targeting Malignant Melanoma – An Application for Mass Spectrometry Imaging
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Myriad reloaded and ready for the next round? The Association for Molecular Pathology v USPTO., 689 F.3d 1303 (Fed. Cir. 2012)
(
- Contribution to journal › Article
-
Mark
Personalizing pancreatic cancer medicine: what are the challenges?
(
- Contribution to journal › Scientific review
- 2011
-
Mark
State-of-the-art MS technology applications in lung disease.
(
- Contribution to journal › Scientific review
- 2010
-
Mark
Molecular serum portraits - A step towards personalized medicine
2010)(
- Thesis › Doctoral thesis (compilation)